Editors’ Picks, September 2024: Reducing Pancreatic Cancer Risk, Immunotherapy for Dogs, and More
This month, AACR's journals editors highlighted factors that may reduce pancreatic cancer risk, a new humanized mouse model, and...
This month, AACR's journals editors highlighted factors that may reduce pancreatic cancer risk, a new humanized mouse model, and...
August’s edition of Editors’ Picks includes biomarkers of immunotherapy response, individualized colorectal screening guidelines, and other exciting research.
New cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening...
Clinical trials for dogs with cancer can extend the lives of our four-legged friends while revealing insights about cancer...
The AACR journal editors' picks for July 2024 include a review of the risks from CAR T-cell therapy, advances...
Researchers are making progress on genetic classification of sarcoma tumors, the use of T-cell therapy, and nanomedicine delivery.
The drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
The June edition of Editors’ Picks includes a clinical trial that clinched a new FDA approval for adagrasib, a...